Pfizer’s Lorviqua recommended by NICE for lung cancer Oct 8, 2025 | News, Regulatory Lung cancer is the leading cause of cancer-related deaths worldwide Read More
Roche’s small cell lung cancer therapy approved by FDA Oct 6, 2025 | News, Regulatory This is the first and only approved combination therapy for extensive-stage small cell lung cancer Read More
Eli Lilly’s Inluriyo approved by FDA for breast cancer Oct 3, 2025 | News, Regulatory The oral drug can be used to treat advanced or metastatic breast cancer Read More
FDA accepts supplemental New Drug Application for Pharming’s paediatric immunodeficiency therapy Oct 3, 2025 | News, Regulatory If approved, the treatment would be the first for children with APDS under 12 years Read More
J&J’s Tremfya approved by FDA for children with plaque psoriasis and psoriatic arthritis Oct 2, 2025 | News, Regulatory The drug is the first IL-23 inhibitor approved for children from the age of six Read More